last update: July 19, 2007
1. Availability of Solvation Models
2. Availability of NOPOL Keyword
3. Reaction Rates in the Condensed Phase
1. Availability of Solvation Models
An aq
means that the method is present, but can be used for aqueous solvent only
An E
means that the method is present, but cannot be used to optimize geometries in solution
A G means that the method is present including analytic gradients
for both unrestricted and restricted wave functions.
A - means that the method is not available.
|
|
|
|
MN-GSM |
ZINDO-MN |
|
|
|
HONDOPLUS |
SMXGAUSS |
|
|
|
|
|
|
|
|
|
|
|
|
SM5.0
|
|
|
|
|
|
|
|
|
|
|
(no quantal Hamiltonian)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM5.2
|
|
|
|
|
|
|
|
|
|
|
AM1
|
|
|
|
|
|
|
|
|
|
|
PM3
|
|
|
|
|
|
|
|
|
|
|
MNDO
|
|
|
|
|
|
|
|
|
|
|
MNDO/d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM5.4
|
|
|
|
|
|
|
|
|
|
|
AM1
|
|
|
|
|
|
|
|
|
|
|
PM3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM5.42
|
|
|
|
|
|
|
|
|
|
|
HF/MIDI!
|
|
|
|
|
|
|
|
|
|
|
HF/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
HF/6-31G*
|
|
|
|
|
|
|
|
|
|
|
BPW91/MIDI!
|
|
|
|
|
|
|
|
|
|
|
BPW91/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3LYP/MIDI!
|
|
|
|
|
|
|
|
|
|
|
BPW91/6-31G*
|
|
|
|
|
|
|
|
|
|
|
HF/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
HF/cc-pVDZ
|
|
|
|
|
|
|
|
|
|
|
BPW91/DZVP
|
|
|
|
|
|
|
|
|
|
|
AM1
|
|
|
|
|
|
|
|
|
|
|
PM3
|
|
|
|
|
|
|
|
|
|
|
INDO/S
|
|
|
|
|
|
|
|
|
|
|
INDO/S2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM5.43
|
|
|
|
|
|
|
|
|
|
|
HF/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM6
|
|
|
|
|
|
|
|
|
|
|
BLYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
BLYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
BLYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
BLYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
B3LYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
BPW91/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
BPW91/6-31G*
|
|
|
|
|
|
|
|
|
|
|
BPW91/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
BPW91/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
B3PW91/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3PW91/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3PW91/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
B3PW91/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
G96LYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
G96LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
G96LYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
G96LYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM6T
|
|
|
|
|
|
|
|
|
|
|
B3LYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM8
|
|
|
|
|
|
|
|
|
|
|
B3LYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SM8T
|
|
|
|
|
|
|
|
|
|
|
B3LYP/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
B3LYP/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
MPWX/MIDI!6D
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G*
|
|
|
|
|
|
|
|
|
|
|
MPWX/6-31+G**
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
SM5C
|
|
|
|
|
|
|
|
|
|
|
AM1
|
|
|
|
|
|
|
|
|
|
|
PM3
|
|
|
|
|
|
|
|
|
|
|
MNDO/d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VEM42
|
|
|
|
|
|
|
|
|
|
|
INDO/S
|
|
|
|
|
|
|
|
|
|
|
INDO/S2
|
|
|
|
|
|
|
|
|
|
2. Availability of NOPOL Keyword
The NOPOL option is supported by AMM (SM5.2) AMSOL, GAMESSPLUS, and MN-GSM.
3. Reaction Rates in the Condensed Phase
We have developed five levels:
I. For organic reactions in liquid solutions
SES: Seperable Equilibrium Solvation (Refs. 1 and 2)
ESP: Equilibrium Solvation Path
(Refs. 1 and 2)
NES: Non-Equilibrium Solvation (Ref.
3)
II. For enzyme reactions
SZP: Secondary-Zone Poential (Ref. 4)
ESZ: Equilibrium Secondary Zone
(Ref. 5)
References:
1."Interface of Electronic Structure and Dynamics for Reactions in Solution," Y.-Y. Chuang, C. J. Cramer, and D. G. Truhlar, International Journal of Quantum Chemistry 70, 887-896 (1998). (Sanibel issue)
2."Direct Dynamics for Free Radical Kinetics in Solution: Solvent Effect on the Rate Constant for the Reaction of Methanol with Atomic Hydrogen," Y.-Y. Chuang, M. L. Radhakrishnan, P. L. Fast, C. J. Cramer, and D. G. Truhlar, Journal of Physical Chemistry 103, 4893-4909 (1999).
3."Nonequilibrium Solvation Effects for a Polyatomic Reaction in Solution," Y.-Y. Chuang and D. G. Truhlar, Journal of the American Chemical Society, 121, 10157-10167 (1999).
4."Quantum Mechanical Dynamical Effects in an Enzyme-Catalyzed Proton-Transfer Reaction," C. Alhambra, J. Gao, J. C. Corchado, J. Villà, and D. G. Truhlar, Journal of the American Chemical Society 121, 2253-2258 (1999).
5. "Variational Transition State Theory and Multidimensional Tunneling for Simple and Complex Reactions in the Gas Phase, Solids, Liquids, and Enzymes," D. G. Truhlar, in Isotope Effects in Chemistry and Biology," edited by A. Kohen and H.-H. Limbach (Marcel Dekker, Inc., New York, published in 2005, copyright 2006), pp. 579-620.
The following chart shows the capabilities of the various programs for carrying out these calculations
|
|
AMSOLRATE |
CHARMMRATE |
GAMESSPLUSRATE |
GAUSSRATE |
MORATE |
POLYRATE |
|
|
|
|
|
|
|
|
|
Gas
|
|
|
|
|
|
|
|
SES
|
|
|
|
|
|
|
|
ESP
|
|
|
|
|
|
|
|
NES
|
|
|
|
|
|
|
|
SZP
|
|
|
|
|
|
|
|
ESZ
|
|
|
|
|
|
|
Explanations:
K
= by SES keyword (tunneling capabilities of keyword option: can do ZCT,
SCT, or LCT)
I = by VTST-ISPE keyword (tunneling capabilities of VTST-ISPE option:
can do ZCT or SCT but not LCT)
(1) = available beginning with POLYRATE 8.2
(2) = scheduled for inclusion in CHARMM 27